Glutaminyl Cyclase, Diseases, and Development of Glutaminyl
Por um escritor misterioso
Descrição
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends - ScienceDirect
Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells
IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes
Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors
Glutaminyl cyclase (QC) converts N-aminoterminal glutamate residue to
is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM.Glutaminyl Cyclase Inhibitor 1 is compound 23[1].[1]. Li M, et al. Synthesis and
Glutaminyl Cyclase Inhibitor 1
Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation
Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
